OnKure Therapeutics Statistics
Total Valuation
OKUR has a market cap or net worth of $57.77 million. The enterprise value is -$51.90 million.
Important Dates
The last earnings date was Monday, March 10, 2025, after market close.
| Earnings Date | Mar 10, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
OKUR has 13.44 million shares outstanding. The number of shares has increased by 1,114.54% in one year.
| Current Share Class | 12.75M |
| Shares Outstanding | 13.44M |
| Shares Change (YoY) | +1,114.54% |
| Shares Change (QoQ) | -4.65% |
| Owned by Insiders (%) | 16.89% |
| Owned by Institutions (%) | 49.38% |
| Float | 4.30M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.55 |
| P/TBV Ratio | 0.56 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 10.73, with a Debt / Equity ratio of 0.01.
| Current Ratio | 10.73 |
| Quick Ratio | 10.52 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -361.75 |
Financial Efficiency
Return on equity (ROE) is -79.92% and return on invested capital (ROIC) is -50.10%.
| Return on Equity (ROE) | -79.92% |
| Return on Assets (ROA) | -44.43% |
| Return on Invested Capital (ROIC) | -50.10% |
| Return on Capital Employed (ROCE) | -51.29% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.15M |
| Employee Count | 46 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 5.24 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 28.56 |
| Average Volume (20 Days) | 31,531 |
Short Selling Information
The latest short interest is 1.07 million, so 7.99% of the outstanding shares have been sold short.
| Short Interest | 1.07M |
| Short Previous Month | 1.10M |
| Short % of Shares Out | 7.99% |
| Short % of Float | 24.96% |
| Short Ratio (days to cover) | 10.28 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -53.54M |
| Pretax Income | n/a |
| Net Income | -52.67M |
| EBITDA | -53.08M |
| EBIT | -53.54M |
| Earnings Per Share (EPS) | -$15.28 |
Full Income StatementBalance Sheet
The company has $110.76 million in cash and $1.09 million in debt, giving a net cash position of $109.68 million or $8.16 per share.
| Cash & Cash Equivalents | 110.76M |
| Total Debt | 1.09M |
| Net Cash | 109.68M |
| Net Cash Per Share | $8.16 |
| Equity (Book Value) | 103.83M |
| Book Value Per Share | 7.78 |
| Working Capital | 102.47M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$51.12 million and capital expenditures -$52,000, giving a free cash flow of -$51.17 million.
| Operating Cash Flow | -51.12M |
| Capital Expenditures | -52,000 |
| Free Cash Flow | -51.17M |
| FCF Per Share | -$3.81 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |